The findings of this study show that in the early stage of RA, GC and disease activity contribute to reduction of BMD and suggest that GC exposure has a significant impact on bone microarchitecture mediated by the suppression of Wnt signaling and the modulation of OPG/RANKL system. The gene discussed is TNFSF11; the disease is rheumatoid arthritis.